Literature DB >> 10829089

Angiotensin II-mediated vascular smooth muscle cell growth signaling.

T Inagami1, S Eguchi.   

Abstract

The mechanism by which Ang II stimulates the growth of vascular smooth muscle cells was investigated by measuring the phosphorylation of mitogen-activated protein kinases ERK 1 and ERK 2. Ca2+ ionophore was found to have effects practically analogous to Ang II. We found that the signaling pathway involves the activation of epidermal growth factor receptor (EGFR) kinase, activation of the adaptor proteins Shc and Grb2, and the small G-protein Ras. Although the mechanism of AT1- (or Ca2+)-induced activation of EGFR is not yet clear, we have found that calcium-dependent protein kinase CAKss/PYK2 and c-Src are involved in this process. These studies indicate a transactivation mechanism that utilizes EGFR as a bridge between a Gq-coupled receptor and activation of phosphotyrosine generation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10829089     DOI: 10.1590/s0100-879x2000000600002

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  4 in total

Review 1.  Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases.

Authors:  Seonwook Kim; Venkateswaran Subramanian; Ahmed Abdel-Latif; Sangderk Lee
Journal:  Metab Syndr Relat Disord       Date:  2020-02-20       Impact factor: 1.894

Review 2.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  Regulation of muscle satellite cell activation and chemotaxis by angiotensin II.

Authors:  Adam P W Johnston; Jeff Baker; Leeann M Bellamy; Bryon R McKay; Michael De Lisio; Gianni Parise
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

Review 4.  Anti-hypertensive Herbs and their Mechanisms of Action: Part I.

Authors:  Sara S Al Disi; M Akhtar Anwar; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-01-19       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.